Frankfurt - Delayed Quote EUR
Bicycle Therapeutics plc (50BA.F)
7.05
+0.35
+(5.22%)
At close: May 9 at 3:29:01 PM GMT+2
Insider Purchases Last 6 Months
Shares | Transactions | |
---|---|---|
Purchases | 0 | 0 |
Sales | -- | 0 |
Net Shares Purchased (Sold) | 0 | 0 |
Total Insider Shares Held | 1.01M | -- |
% Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
Shares | |
---|---|
Net Shares Purchased (Sold) | -- |
% Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
Insider | Transaction | Type | Value | Date |
---|---|---|---|---|
LEE KEVIN Chief Executive Officer | Sale at price 7.48 - 8.02 per share. | Direct | 43,612 | Apr 3, 2025 |
MILNES ALISTAIR Chief Operating Officer | Sale at price 7.48 - 8.02 per share. | Direct | 16,851 | Apr 3, 2025 |
HANNAY MICHAEL CHARLES FERGUSON Officer | Sale at price 7.48 - 8.02 per share. | Direct | 5,735 | Apr 3, 2025 |
YOUNG ALETHIA R. Chief Financial Officer | Sale at price 8.02 per share. | Direct | 1,724 | Apr 2, 2025 |
THOMPSON TRAVIS ALVIN Officer | Sale at price 14.09 - 15.00 per share. | Direct | 67,293 | Jan 6, 2025 |
SKYNNER MICHAEL Chief Technology Officer | Sale at price 14.09 - 14.75 per share. | Direct | 60,120 | Jan 3, 2025 |
LEE KEVIN Chief Executive Officer | Sale at price 14.09 - 14.75 per share. | Direct | 172,952 | Jan 3, 2025 |
CROCKETT NIGEL Officer | Sale at price 14.09 - 14.75 per share. | Direct | 50,200 | Jan 3, 2025 |
MILNES ALISTAIR Chief Operating Officer | Sale at price 14.09 - 14.75 per share. | Direct | 78,310 | Jan 3, 2025 |
HANNAY MICHAEL CHARLES FERGUSON Officer | Sale at price 14.09 - 14.75 per share. | Direct | 30,000 | Jan 3, 2025 |
BAKER BROS ADVISORS L.P. Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) at price 0.00 per share. | Indirect | 0 | Jan 2, 2025 |
KENDER RICHARD N Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 2, 2025 |
LEGAULT PIERRE Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 2, 2025 |
GUTIERREZ-RAMOS JOSE-CARLOS Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 2, 2025 |
SKYNNER MICHAEL Chief Technology Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 2, 2025 |
LEE KEVIN Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 2, 2025 |
CROCKETT NIGEL Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 2, 2025 |
MILNES ALISTAIR Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 2, 2025 |
THOMPSON TRAVIS ALVIN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 2, 2025 |
HANNAY MICHAEL CHARLES FERGUSON Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 2, 2025 |
BAKER BROS ADVISORS L.P. Director and Beneficial Owner of more than 10% of a Class of Security | Purchase at price 13.50 - 15.34 per share. | Indirect | 21,230,385 | Dec 16, 2024 |
THOMPSON TRAVIS ALVIN Officer | Sale at price 24.77 - 25.21 per share. | Direct | 157,114 | Nov 11, 2024 |
THOMPSON TRAVIS ALVIN Officer | Conversion of Exercise of derivative security at price 1.87 - 9.82 per share. | Direct | 14,608 | Nov 11, 2024 |
MILNES ALISTAIR Chief Operating Officer | Sale at price 22.26 per share. | Direct | 21,637 | Oct 3, 2024 |
HANNAY MICHAEL CHARLES FERGUSON Officer | Sale at price 22.26 per share. | Direct | 5,498 | Oct 3, 2024 |
SKYNNER MICHAEL Chief Technology Officer | Sale at price 19.64 per share. | Direct | 18,992 | Jul 3, 2024 |
BAKER BROS ADVISORS L.P. Beneficial Owner of more than 10% of a Class of Security | -- | Indirect | -- | Jun 17, 2024 |
BAKER BROS ADVISORS L.P. Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) at price 0.00 per share. | Indirect | 0 | Apr 18, 2024 |
KEEN NICHOLAS Officer | Sale at price 23.81 per share. | Direct | 18,810 | Apr 3, 2024 |
LEE KEVIN Chief Executive Officer | Sale at price 23.81 per share. | Direct | 75,192 | Apr 3, 2024 |
MILNES ALISTAIR Chief Operating Officer | Sale at price 23.81 per share. | Direct | 22,739 | Apr 3, 2024 |
THOMPSON TRAVIS ALVIN Officer | Sale at price 23.81 per share. | Direct | 3,619 | Apr 3, 2024 |
KEEN NICHOLAS Officer | Sale at price 17.50 per share. | Direct | 46,200 | Jan 3, 2024 |
CROCKETT NIGEL Officer | Sale at price 17.50 per share. | Direct | 46,252 | Jan 3, 2024 |
MILNES ALISTAIR Chief Operating Officer | Sale at price 17.50 per share. | Direct | 46,252 | Jan 3, 2024 |
THOMPSON TRAVIS ALVIN Officer | Sale at price 17.50 per share. | Direct | 10,570 | Jan 3, 2024 |
JORDAN VERONICA G H Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 2, 2024 |
KENDER RICHARD N Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 2, 2024 |
GUTIERREZ-RAMOS JOSE-CARLOS Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 2, 2024 |
KEEN NICHOLAS Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 2, 2024 |
CROCKETT NIGEL Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 2, 2024 |
MILNES ALISTAIR Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 2, 2024 |
YOUNG ALETHIA R. Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 2, 2024 |
THOMPSON TRAVIS ALVIN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 2, 2024 |
KEEN NICHOLAS Officer | Sale at price 20.00 per share. | Direct | 5,440 | Oct 3, 2023 |
SKYNNER MICHAEL Chief Technology Officer | Sale at price 25.10 per share. | Direct | 11,320 | Jul 3, 2023 |
LEE KEVIN Chief Executive Officer | Sale at price 25.10 per share. | Direct | 37,600 | Jul 3, 2023 |
Related Tickers
HTD.MU Corcept Therapeutics Inc
62.94
+1.42%
HQ1.MU Oruka Therapeutics Inc. R
8.50
+1.19%
22Z.SG Zealand Pharma A/S
56.18
-6.30%
GNRO.PA GeNeuro SA
0.0748
+11.31%
OCD1.MU ChromaDex Corp
8.20
+2.50%
NXOA.BE Nicox SA
0.2280
-1.51%
GON.DU Geron Corp
1.0455
-8.85%
IXI.L IXICO plc
9.00
-7.22%
PI3.DU Gubra AS
53.35
+4.61%
APE1.SG Addex Therapeutics Ltd
6.75
0.00%